SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001516551-24-000085
Filing Date
2024-09-04
Accepted
2024-09-04 17:59:16
Documents
16
Period of Report
2024-09-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K skye-20240903.htm   iXBRL 8-K 42136
2 EX-10.1 skye_executiveemploymentag.htm EX-10.1 63896
3 EX-99.1 a240903_skyexnrxarora.htm EX-99.1 15743
  Complete submission text file 0001516551-24-000085.txt   270121

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT skye-20240903.xsd EX-101.SCH 2177
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT skye-20240903_def.xml EX-101.DEF 2386
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT skye-20240903_lab.xml EX-101.LAB 21921
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT skye-20240903_pre.xml EX-101.PRE 12620
18 EXTRACTED XBRL INSTANCE DOCUMENT skye-20240903_htm.xml XML 2537
Mailing Address 11250 EL CAMINO REAL, SUITE 100 SAN DIEGO CA 92130
Business Address 11250 EL CAMINO REAL, SUITE 100 SAN DIEGO CA 92130 (858) 410-0266
Skye Bioscience, Inc. (Filer) CIK: 0001516551 (see all company filings)

IRS No.: 450692882 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42009 | Film No.: 241278573
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)